Last update 01 Nov 2024

Summit (Oxford) Ltd.

Subsidiary Company|
2019|
United Kingdom
|
www.summitplc.com

Overview

Related

5
Clinical Trials associated with Summit (Oxford) Ltd.
EUCTR2017-001642-10-DE / Not yet recruitingPhase 3
A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole (200 mg, bid) for 10 days with vancomycin (125 mg, qid) for 10 days in the treatment of Clostridium difficile infection (CDI).
PER-005-19 / SuspendedPhase 3
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED STUDYTO COMPARE THE EFFICACY AND SAFETY OF RIDINILAZOLE (200 MG,BID) FOR 10 DAYS WITH VANCOMYCIN (125 MG, QID) FOR 10 DAYS INTHE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION (CDI).
EUCTR2015-001967-38-GB / Not yet recruitingPhase 1
A Phase I, 2-Part, Open-label, Multiple Oral Dose Study of the Safety, Tolerability and Pharmacokinetics of up to 2 Formulations of SMT C1100 in Healthy Adult Male Subjects and a Selected Formulation of SMT C1100 in Paediatric Subjects with Duchenne Muscular Dystrophy (DMD) - SMTC11004 - Phase 1 study in healthy volunteers and DMD patients
100 Clinical Results associated with Summit (Oxford) Ltd.
Login to view more data
0 Patents (Medical) associated with Summit (Oxford) Ltd.
Login to view more data
100 Deals associated with Summit (Oxford) Ltd.
Login to view more data
100 Translational Medicine associated with Summit (Oxford) Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

No data posted
Login to keep update

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free